Oracle Layoffs: No ‘6 AM Email’ on September 1—Why September 15 Now Matters

Oracle employees braced for cuts on September 1 but no mass email arrived. Reports now point to September 15, with September 30 also mentioned, though Oracle hasn’t confirmed layoffs. Estimates suggest 7,000–10,000 roles globally amid a capital-intensive AI buildout and $55.7 billion in FY2026 capex. September 1 came and went at Oracle without the mass … Read more

‘Dark Side Of NRI Life’: US-Based Man Reveals $2,500 Dental Bill, Says India Treatment Is Cheaper

A US-based NRI revealed a $2,500 (approximately ₹2.37 lakh) dental bill for a tooth extraction despite having health insurance. He compared the cost with India, where he claimed the same treatment could cost ₹15,000 to ₹20,000. Living abroad can offer higher earnings, but the cost of everyday services, particularly healthcare, can be a major concern … Read more

DELL Stock Shrugs Off Market Slump As Analysts See ‘Surging’ AI Demand After ‘Blowout’ Q2 Beat

BofA said demand “continues to outpace supply” and raised its Dell price target to $600 from $505. Citi called the quarter a “clear beat” amid “surging” demand and also raised its target to $600. JPMorgan described the results as “another robust quarter” and lifted its price target to $635 from $565. Melius Research raised its … Read more

Uttarakhand CM Dhami on modern education for all, historic beginning

Uttarakhand CM Pushkar Singh Dhami emphasised the state’s commitment to providing quality, modern education for all children, calling the recognition of 26 madrasas a historic beginning towards a structured educational framework in the state. Uttarakhand Chief Minister Pushkar Singh Dhami on Wednesday emphasised the state’s commitment to providing quality, modern, and career-oriented education to all … Read more

Why Did RARE Stock Slump 46% After-Hours?

Ultragenyx said the late-stage Aspire study of apazunersen, also known as GTX-102, did not meet its primary goal or key backup goal in a late-stage trial. Chief Executive Emil Kakkis said the company was disappointed, “even more” for families who had invested years in the research. Ultragenyx will now review the program and decide whether … Read more

HP Assembly: BJP Slams Govt for Withholding Recruitment Information

BJP legislators accused the Himachal Pradesh government of withholding recruitment details from the State Selection Commission, an issue raised in three consecutive Assembly sessions. CM Sukhu cited past irregularities as a reason for the delay. Row Over Recruitment Data in Assembly BJP legislators on Wednesday accused the Himachal Pradesh government of withholding crucial information on … Read more

Punjab HC hears Rajoana’s plea for eye treatment at private hospital

The Punjab and Haryana High Court disposed of a plea by Balwant Singh Rajoana, convicted in the Beant Singh assassination case, seeking eye treatment at a private hospital. The court directed that his treatment continue at PGI Chandigarh. High Court Rules on Rajoana’s Eye Treatment Plea The Punjab and Haryana High Court on Wednesday heard … Read more

India has a ‘really hot hand’ right now, says USIBC’s Atul Keshap

Hailing India’s 7.8% real GDP growth in Q1 FY27, USIBC President Atul Keshap said India has a ‘really hot hand right now’ and that global investors are reappraising their view of the country, recognizing its strong growth story and reforms. India’s ‘Hot Hand’ Draws Global Investors Hailing India’s 7.8 per cent real GDP growth in … Read more

Microsoft Discloses Exact Azure Sales Figures For The First Time Following Longstanding Investor Demand

Microsoft used to publish only the percentage growth rate for its Azure cloud computing division, its key growth driver. Microsoft will start providing specific quarterly revenue metrics for its Azure cloud platform, addressing years of Wall Street criticism over incomplete disclosure.  Historical financial data released by the tech giant showed Azure sales steadily climbing to … Read more

QURE Stock Fades After AMT-130 filing — But William Blair Sees 58% Upside

uniQure announced it had submitted a Biologics License Application to the FDA seeking accelerated approval of ifezuntirgene inilparvovec, or AMT-130, for Huntington’s disease. William Blair noted AMT-130 will potentially be the first approved therapy to treat the underlying cause of Huntington’s in the first half of 2027. It views the biologics license application acceptance as … Read more